During the past decade, Huntington Medical Research Institutes conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 8 clinical trials were completed, i.e. on average, 160% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Huntington Medical Research Institutes" #1 sponsor was "Gilead Sciences" with 4 trials, followed by "Huntington Medical Research Institutes" with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Conatus Pharmaceuticals Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Huntington Medical Research Institutes" #1 collaborator was "InterMune" with 1 trials as a collaborator, "Novartis" with 1 trials as a collaborator, "Shanghai Sundise Traditional Chinese Medicine Co., Ltd." with 1 trials as a collaborator and "U.S. Army Medical Research and Development Command" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Huntington Medical Research Institutes" are "Hepatitis C" (3 trials), "Chronic HBV Infection" (2 trials), "HBV" (2 trials), "Nonalcoholic Fatty Liver Disease" (2 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Huntington Medical Research Institutes" in a lesser frequency.

Most popular intervention types in "Huntington Medical Research Institutes" are "Drug" (12 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "PF-05221304" (2 trials), "Ribavirin" (2 trials), "TAF" (2 trials) and "TAF Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Huntington Medical Research Institutes" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Huntington Medical Research Institutes". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Huntington Medical Research Institutes, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Huntington Medical Research Institutes, 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".